TheraRadar
Clinical-Stage Companies / International Partnership for Microbicides

International Partnership for Microbicides

Pre-Approval PRO BETA
🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 8/1/2022

34
Total Trials
5
Phase 3
7
Phase 2
0
Recruiting
209
Score

Pipeline by Phase

Phase 3
5
Phase 2
7
Phase 1
26

Therapeutic Focus

HIV Infections Human Immunodeficiency Virus HIV Pharmacokinetics HIV Prevention

Clinical Trials (34)

NCT01617096 Phase 3 COMPLETED

Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women

Started: 7/24/2012

NCT02862171 Phase 3 COMPLETED

To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women

Started: 7/12/2016

NCT02858037 Phase 3 COMPLETED

Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women

Started: 7/18/2016

NCT01337583 Phase 3 WITHDRAWN

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Started: 7/1/2011

NCT01337570 Phase 3 WITHDRAWN

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Started: 7/1/2011

NCT02010593 Phase 2 COMPLETED

Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women

Started: 12/1/2013

NCT02028338 Phase 2 COMPLETED

Study of Dapivirine Vaginal Ring (VR) in Adolescents

Started: 6/27/2014

NCT03074786 Phase 2 WITHDRAWN

Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)

Started: 11/1/2017

NCT05041699 Phase 1 COMPLETED

PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

Started: 6/20/2022

NCT05416021 Phase 1 COMPLETED

Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008

Started: 8/1/2022

NCT00799058 Phase 1 COMPLETED

A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

Started: 7/6/2009

NCT03467347 Phase 1 COMPLETED

PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

Started: 7/17/2018

NCT03234400 Phase 1 COMPLETED

A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings

Started: 12/4/2017

NCT02855346 Phase 1 COMPLETED

PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel

Started: 5/3/2017

NCT01755741 Phase 1 COMPLETED

Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng

Started: 2/1/2013

NCT02808949 Phase 1 COMPLETED

Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women

Started: 2/1/2015

NCT01755754 Phase 1 COMPLETED

A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring

Started: 8/1/2013

NCT02920827 Phase 1 COMPLETED

Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring

Started: 8/1/2009

NCT01731574 Phase 1 COMPLETED

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

Started: 12/1/2012

NCT01924091 Phase 1 COMPLETED

PK/PD of Single Dose Dapivirine Vaginal Film

Started: 9/1/2013

NCT01548560 Phase 1 COMPLETED

Assessing the Safety of Dapivirine Gel and Film Formulations

Started: 8/1/2012

NCT01277640 Phase 1 COMPLETED

Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures

Started: 3/1/2011

NCT02346084 Phase 1 COMPLETED

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults

Started: 1/1/2015

NCT02858024 Phase 1 COMPLETED

A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine

Started: 1/12/2015

NCT02847286 Phase 1 COMPLETED

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)

Started: 9/1/2015

NCT02877979 Phase 1 COMPLETED

Evaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women

Started: 11/18/2015

NCT03044379 Phase 1 WITHDRAWN

Dapivirine Gel Rectal Safety and PK Study

Started: 9/29/2015

NCT01952561 Phase 1 COMPLETED

Expanded Use PK of Dapivirine Vaginal Ring

Started: 11/1/2013

NCT01363037 Phase 1 COMPLETED

Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

Started: 11/1/2011

NCT00917904 Phase 1 COMPLETED

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

Started: 7/1/2009

NCT00917891 Phase 1 COMPLETED

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

Started: 11/1/2009

NCT01242579 Phase 1 WITHDRAWN

A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium

Started: 1/1/2011

NCT01071174 Phase 1 COMPLETED

A Safety Study of Dapivirine Vaginal Ring in Africa

Started: 4/1/2010

NCT01144676 Phase 1 COMPLETED

A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring

Started: 4/1/2010

Drug Candidates

dapivirine Dapivirine Vaginal Ring Placebo Vaginal Ring dapivirine 4789 dapivirine gel 4759 Drug placebo Dapivirine Vaginal Ring-004 VR: 200 mg DPV + 320 mg LNG Dapivirine miconazole
Activity Status: Stale
Last Trial Started: 8/1/2022
Last Trial Ended: 10/7/2024
Trials (12 months): 0
Completed Trials: 29
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.